Ultrasonographic soft markers of aneuploidy in second trimester: Are we lost?

MedGenMed Medscape General Medicine

Volumn 8, Issue 1, 2006, Pages

  Raniga, Sameer ^a   Desai, P D ^a   Parikh, Hetal ^a  

^a Baroda Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CHROMOSOME ABERRATION; DOWN SYNDROME; ECHOGRAPHY; EVIDENCE BASED PRACTICE; FETUS; FETUS DISEASE; HUMAN; IMAGE ANALYSIS; INCIDENCE; MONOSOMY X; PRENATAL CARE; PRENATAL DIAGNOSIS; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; TRIPLOIDY; TRISOMY 13; TRISOMY 18; CONGENITAL MALFORMATION; FEMALE; PREGNANCY;

ABNORMALITIES; ANEUPLOIDY; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; ULTRASONOGRAPHY, PRENATAL;

EID: 32544439376     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Shipp TD, Benacerraf BR. Second trimester ultrasound screening for chromosomal abnormalities. Prenat Diagn. 2002;22:296-307. Abstract
2. Adams MM, Erickson JD, Layde PM, Oakley GP. Down's syndrome: recent trends in the United States. JAMA. 1981;246:758-760. Abstract
3. Thompson M, McInnes R, Willard H. Thompson and Thompson Genetics in Medicine, 5th ed. Philadelphia, Pa: WB Saunders; 1991.
4. Nyberg DA, Resta RG, Luthy DA, Hickok DE, Mahony BS, Hirsch JH. Prenatal sonographic findings of Down syndrome: review of 94 cases. Obstet Gynecol. 1990;76:370-377. Abstract.
5. Benacerraf BR, Neuberg D, Bromley B, Frigoletto FD Jr. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med. 1992;11:449-458. Abstract
6. Nicolaides KH, Shawwa L, Brizot M, Snijders RJ. Ultrasonographically detectable markers of fetal chromosomal defects. Ultrasound Obstet Gynecol. 1993;3:56-59. Abstract
7. MacDonald ML, Wagner RM, Slotnick RN. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age. Obstet Gynecol. 1991;77:63-68. Abstract
8. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group. Randomized trial to assess safety and fetal outcome of early and mid-trimester amniocentesis. Lancet. 1998;351:242-247. Abstract
9. Tabor A, Philip J, Madsen M, et al. Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1986;1:1287-1293. Abstract
10. Benacerraf BR, Gelman R, Frigoletto FD Jr. Sonographic identification of second-trimester fetuses with Down's syndrome. N Engl J Med. 1987;317:1371.
11. Winter TC, Uhrich SB, Souter VL, Nyberg DA. The "genetic sonogram": comparison of the index scoring system with the age-adjusted US risk assessment. Radiology. 2000; 215:775-782. Abstract
12. Nyberg DA, Souter VL, El-Bastawissi A, Young S, Luthhardt F, Luthy DA. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med. 2001;20:1053-1063. Abstract
13. Benacerraf BR. Use of sonographic markers to determine the risk of Down syndrome in second-trimester fetuses (editorial). Radiology. 1996;201:619-620. Abstract
14. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol. 1998;12: 8-14. Abstract
15. Stoll C, Dott B, Alembik Y, Roth MP. Evaluation of routine prenatal ultrasound examination in detecting fetal chromosomal abnormalities in a low risk population. Hum Genet. 1993;91:37-41. Abstract
16. Hill LM. The sonographic detection of trisomies 13, 18, and 21. Clin Obstet Gynecol. 1996;39:831-850. Abstract
17. Vintzileos AM, Campbell WA, Guzman ER, Smulian JC, McLean DA, Ananth CV. Second-trimester ultrasound markers for detection of trisomy 21: which markers are best? Obstet Gynecol. 1997;89: 941-944.
18. Nadel AS, Bromley B, Frigoletto FD Jr, Benacerraf BR. Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram? J Ultrasound Med. 1995;14:297-302.
19. Yeo L, Guzman ER, Day-Salvatore D, Walters C, Chavez D, Vintzileos AM. Prenatal detection of fetal trisomy 18 through abnormal sonographic features. J Ultrasound Med. 2003;22:581-590. Abstract
20. DeVore GR. Second trimester ultrasonography may identify 77 to 97% of fetuses with trisomy 18. J Ultrasound Med. 2000;19:565-576. Abstract
21. Stewart T. Screening for aneuploidy: the genetic sonogram. Obstet Gynecol Clin North Am. 2004; 31:21-33. Abstract
22. Bromley B, Lieberman E, Shipp TD, Benacerraf BR.The genetic sonogram - a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med. 2002;21:1087-1096. Abstract
23. Benacerraf BR, Barrs VA, Laboda LA. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol. 1985;151:1078-1079. Abstract
24. Benacerraf BR, Frigoletto FD Jr, Laboda L. Sonographic diagnosis of Down syndrome in the second trimester. Am J Obstet Gynecol. 1985;153:49-52. Abstract
25. Benacerraf BR, Frigoletto FD Jr. Soft tissue nuchal fold in the second-trimester fetus: standards for normal measurements compared with those in Down syndrome. Am J Obstet Gynecol. 1987;157:1146-1149. Abstract
26. Gray DL, Crane JP. Optimal nuchal skin-fold thresholds based on gestational age for prenatal detection of Down syndrome. Am J Obstet Gynecol. 1994;171:1282-1286. Abstract
27. Borrell A, Costa D, Martinez JM, et al. Early midtrimester fetal nuchal thickness: effectiveness as a marker for Down syndrome. Obstet Gynecol. 1996;175:45-49.
28. Locatelli A, Piccoli MG, Vergani P, et al. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome. Am J Obstet Gynecol. 2000;182:192-197. Abstract
29. Bahado-Singh RO, Oz UA, Kovanci E, et al. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk. J Matern Fetal Med. 1999;8:37-43. Abstract
30. Tannirandorn Y, Manotaya S, Uerpairojkit B, Tanawattanacharoen S, Charoenvidhya D, Phaosavasdi S. Cut-off criteria for second-trimester nuchal skinfold thickness for prenatal detection of Down syndrome in a Thai population. Int J Gynaecol Obstet. 1999;65:137-141. Abstract
31. Rochon M, Eddleman K. Controversial ultrasound findings. Obstet Gynecol Clin North Am. 2004;31:61-99. Abstract
32. Nyberg DA, Dubinsky T, Resta RG, Manony BS, Hickok DE, Luthy DA. Echogenic fetal bowel during the second trimester: clinical importance. Radiology. 1993;188:527-531. Abstract
33. Slotnick RN, Abuhamad AZ, Prognostic implications of fetal echogenic bowel. Lancet. 1996;347:85-87. Abstract
34. Al-Kouatly HB, Chasen ST, Streltzoff J, Chervenak FA. The clinical significance of fetal echogenic bowel. Am J Obstet Gynecol. 2001;185:1035-1038. Abstract
35. Al-Kouatly HB, Chasen ST, Karam AK, Ahner R, Chervenak FA. Factors associated with fetal demise in fetal echogenic bowel. Am J Obstet Gynecol. 2001;185:1039-1043. Abstract
36. Bromley B, Doubilet P, Frigoletto FD Jr, Krauss C, Estroff JA, Benacerraf BR. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis? Obstet Gynecol. 1994;83(5 Pt 1):647-651.
37. Berlin BM, Norton ME, Sugarman EA, Tsipis JE, Allitto BA. Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel. Obstet Gynecol. 1999; 94:135-138. Abstract
38. Lam YH, Tang MH, Lee CP, Tse HY. Echogenic bowel in fetuses with homozygous alpha-thalassemia-1 in the first and second trimesters. Ultrasound Obstet Gynecol. 1999;14:180-182. Abstract
39. Benacerraf BR, Nyberg D, Frigoletto FD Jr. Humeral shortening in second-trimester fetuses with Down syndrome. Obstet Gynecol. 1991; 77:223-227. Abstract
40. Nyberg DA, Resta RG, Luthy DA, Hickok DE, Williams MA. Humerus and femur length shortening in the detection of Down's syndrome. Am J Obstet Gynecol. 1993;168:534-539. Abstract
41. Bahado-Singh RO, Oz AU, Kovanci E, et al. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age. Am J Obstet Gynecol. 1998;179:1627-1631. Abstract
42. Benacerraf BR, Cnann A, Gelman R, Laboda LA, Frigoletto FD Jr. Can sonographers reliably identify anatomic features associated with Down syndrome in fetuses? Radiology. 1989;173:377-380.
43. Johnson MP, Michaelson JE, Barr M Jr, et al. Combining humerus and femur length for improved ultrasonographic identification of pregnancies at increased risk for trisomy 21. Am J Obstet Gynecol. 1995; 172(4 Pt 1):1229-1235.
44. Rodis JF, Vintzileos AM, Fleming AD, et al. Comparison of humerus length with femur length in fetuses with Down syndrome. Am J Obstet Gynecol. 1991;165:1051-1056. Abstract
45. Smith-Bindman R, Hosmer W, Feldstein V, Deeks J, Goldberg J. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis. JAMA. 2001;285:1044-1055. Abstract
46. Stone JL, Eddleman KA, Berkowitz RL. The echogenic intracardiac focus. Contemp Ob/Gyn. 1998;43:73-78.
47. Coco C, Jeant P, Jeanty C. An isolated echogenic heart focus is not an indication for amniocentesis in 12,672 unselected patients. J Ultrasound Med. 2004;23:489-496. Abstract
48. Sotiriadis A, Makrydimas G, Ioannidis JP. Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis. Obstet Gynecol. 2003;101:1009-1016. Abstract
49. Barsoom MJ, Feldman DM, Borgida AF, Esters D, Diana D, Egan JF. Is an isolated fetal cardiac echogenic focus an indication for fetal echocardiography? J Ultrasound Med. 2001;20:1043-1046.
50. Anderson N, Jyoti R. Relationship of isolated fetal intracardiac echogenic focus to trisomy 21 at the mid-trimester sonogram in women younger than 35 years. Ultrasound Obstet Gynecol. 2003; 21:354-358. Abstract
51. Winn VD, Joy Sonson BA, Filly RA. Echogenic intracardiac focus potential for misdiagnosis. J Ultrasound Med. 2003;22:1207-1214. Abstract
52. Filly RA, Benacerraf BR, Nyberg DA,. Hobbins JC. Choroid plexus cyst and echogenic intracardiac focus in women at low risk for chromosomal anomalies. J Ultrasound Med. 2004;23:447-449. Abstract
53. Chitty LS, Chudleigh P, Wright E, Campbell S, Pembrey M. The significance of choroid plexus cysts in an unselected population: results of a multicenter study. Ultrasound Obstet Gynecol. 1998;12:391-397. Abstract
54. Comstock H. Second-trimester sonography and trisomy 18 - the significance of isolated choroid plexus cysts after an examination that includes the fetal hands. J Ultrasound Med. 2004;23:241-245. Abstract
55. Ghidini A, Strobelt N, Locatelli A, Mariani E, Piccoli MG, Vergani P. Isolated fetal choroid plexus cysts: role of ultrasonography in establishment of the risk of trisomy 18. Am J Obstet Gynecol. 2000;182:972-977. Abstract
56. Shields LE, Carpenter LA, Smith KM, Nghiem HV. Ultrasonographic diagnosis of trisomy 18: is it practical in the early second trimester? J Ultrasound Med. 1998;17:327-331.
57. Feuchtbaum LB, Currier RJ, Lorey FW, Cunningham GC. Prenatal ultrasound findings in affected and unaffected pregnancies that are screen-positive for trisomy 18: the California experience. Prenat Diagn. 2000;20:293-299. Abstract
58. Bromley B, Lieberman E, Benacerraf BR. Choroid plexus cysts: not associated with Down syndrome. Ultrasound Obstet Gynecol. 1996;8:232-235. Abstract
59. Yoder PR, Sabbagha RE, Gross SJ, Zelop CM. The second-trimester fetus with isolated choroid plexus cysts: a meta-analysis of risk of trisomies 18 and 21. Obstet Gynecol. 1999;93:869-872. Abstract
60. Gupta JK, Cave M, Lilford RJ, et al. Clinical significance of fetal choroid plexus cysts. Lancet. 1995;346:724-729. Abstract
61. Corteville JE, Kicke JM, Crane JP. Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted? Obstet Gynecol. 1992;79:770-772.
62. Havutcu AE, Nikolopoulos G, Adinkra P, Lamont RF. The association between fetal pyelectasis on second trimester ultrasound scan and aneuploidy among 25, 586 low-risk unselected women. Prenatal Diagn. 2002;22:1201-1206.
63. Benacerraf BR, Mandell J, Estroff JA, Harlow BL, Frigoletto F. Fetal pyelectasis: a possible association with Down syndrome. Obstet Gynecol. 1990;76:58-60. Abstract
64. Ismaili K, Hall M, Donner C, Thomas D, Vermeylen D, Avni FE. Results of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population. Am J Obstet Gynecol. 2003;188:242-246. Abstract
65. Chudleigh PM, Chitty LS, Prembery M, Campbell S. The association of aneuploidy and mild fetal pyelectasis in an unselected population: the result of multicenter population. Ultrasound Obstet Gynecol. 2001;17:197-202. Abstract
66. Vintzileos AM, Egan JFX. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol. 1995;172:837-844. Abstract
67. Snijders RJ, Sebire NJ, Faria M, Patel F, Nicolaides KH. Fetal mild hydronephrosis and chromosomal defects: relation to maternal age and gestation. Fetal Diagn Ther. 1995;10:349-355. Abstract
68. Wickstrom E, Maizels M, Sabbagha RE, Tamura RK, Cohen LC, Pergament E. Isolated fetal pyelectasis: assessment of risk for postnatal uropathy and Down syndrome. Ultrasound Obstet Gynecol. 1996;8:236-240. Abstract
69. Nyberg AS, Bromley B, Frigoletto FD, Benacerraf BR. Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram? J Ultrasound Med. 1995;14:297-302.
70. Vintrileos AM, Uzman ER, Smulian JC, Yeo L, William E, Knuppel RA. Down syndrome risk estimation after normal genetic sonography. Am J Obstet Gynecol. 2002;187:1226-1229. Abstract
71. Egan JF, Kaminsky LM, DeRoche ME, Barsoom MJ, Bargida AF, Benn PA. Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists. Am J Obstet Gynecol. 2002;187:1230-1234. Abstract
72. Benacerraf BR, Nyberg D, Bromley B, Frigoletto FD, Jr. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med. 1992;11:449-458. Abstract
73. Benacerraf BR, Nadel A, Bromley B. Identification of second-trimester fetuses with autosomal trisomy by use of a sonographic scoring index. Radiology. 1994;193:135-140. Abstract
74. Bromley B, Lieberman E, Benacerraf BR. The incorporation of maternal age into the sonographic scoring index for the detection at 14-20 weeks of fetuses with Down's syndrome. Ultrasound Obstet Gynecol. 1997;10:321-324. Abstract
75. Nyberg DA, Luthy DA, Williams MA, Winter TC. Genetic sonogram: computerized assessment of risk for Down syndrome based on obstetric US findings during the second trimester. Radiology. 1996;201:160.
76. Sohl B, Scioscia A, Budorick NE, Moore TR. Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at a prenatal diagnostic center. Am J Obstet Gynecol. 1999;181:898-903. Abstract
77. Vintzileos AM, Campbell WA, Rodis JF, Guzman ER, Smulian JC, McLean DA. Second-trimester ultrasound (U/S) markers for the detection of trisomy-21: which markers are best? [abstract]. J Ultrasound Med. 1997;16(3 Suppl):66.
78. Verdin SM, Economides DL. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry. Br J Obstet Gynaecol. 1998;105:63-67. Abstract
79. Nyberg DA, Luthy DA, Cheng EY, Sheley RC, Resta RG, Williams MA. Role of prenatal ultrasound in women with positive screen for Down syndrome based on maternal serum markers. Am J Obstet Gynecol. 1995;173:1030-1035. Abstract
80. Vintzileos AM, Campbell WA, Rodis JF, Guzman ER, Smulian JC, Knuppel RA. The use of second trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol. 1996;87:948-952. Abstract